| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) |
RFA-CA-25-007 |
03/04/2025 |
10/04/2025 |
P50 |
| Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) |
RFA-CA-25-006 |
03/04/2025 |
10/04/2025 |
U01 |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) |
RFA-CA-25-005 |
03/04/2025 |
10/04/2025 |
R01 |
| Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) |
RFA-CA-25-004 |
03/04/2025 |
10/04/2025 |
R33 |
| Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) |
RFA-CA-25-003 |
03/04/2025 |
10/04/2025 |
R61 |
| Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) |
RFA-CA-25-002 |
03/04/2025 |
10/04/2025 |
R33 |
| Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) |
RFA-CA-25-001 |
03/04/2025 |
10/04/2025 |
R61 |
| Mechanistic links between diet, lipid metabolism, and tumor growth and progression (U01 Clinical Trial Not Allowed) |
PAR-25-119 |
01/14/2025 |
10/24/2025 |
U01 |
| Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed) |
PAR-25-118 |
01/14/2025 |
10/24/2025 |
UH2 |
| Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed) |
PAR-25-044 |
01/16/2025 |
01/08/2028 |
R21 |
| Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional) |
PAR-25-043 |
01/05/2025 |
01/08/2028 |
R01 |
| Notice of Special Interest: Women’s Health Research |
NOT-OD-24-079 |
03/26/2024 |
11/05/2027 |
N/A |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) |
RFA-OD-24-011 |
11/04/2024 |
12/05/2026 |
R50 |
| Building Sustainable Software Tools for Open Science (R03 Clinical Trial Not Allowed) |
RFA-OD-24-010 |
11/04/2024 |
12/05/2026 |
R03 |
| Notice of Special Interest (NOSI): Understanding the Basic Mechanisms of Immune-related Adverse Events (irAEs) in Cancer Immunotherapy |
NOT-CA-24-055 |
07/11/2024 |
11/06/2027 |
N/A |
| Support for Research Excellence – First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed) |
PAR-24-145 |
04/29/2024 |
01/08/2027 |
R16 |
| Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed) |
PAR-24-144 |
04/29/2024 |
01/08/2027 |
R16 |
| Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) |
PAR-24-311 |
01/05/2025 |
01/08/2028 |
R01 |
| Notice of Special Interest (NOSI): Exploratory Cancer Immunology Projects and Technologies (ExCITe) |
NOT-CA-24-016 |
12/05/2023 |
11/17/2026 |
R21 |
| Notice of Special Interest (NOSI): Research Projects to Develop Oncoaging Models for Cancer Research |
NOT-CA-23-092 |
10/16/2023 |
07/31/2027 |
N/A |
| Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) |
PAR-24-306 |
01/05/2025 |
09/08/2026 |
R01 |
| Notice of Special Interest (NOSI): Research on HIV-associated Malignancies |
NOT-CA-23-070 |
06/08/2023 |
09/08/2026 |
N/A |
| Notice of Special Interest (NOSI): RNA Modifications in Cancer Biology |
NOT-CA-23-060 |
04/17/2023 |
01/08/2026 |
N/A |
| Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications |
NOT-EB-23-002 |
04/14/2023 |
05/17/2026 |
N/A |
| Adaptive Biomaterials for Cancer Biology |
NOT-CA-23-030 |
01/10/2023 |
05/07/2025 |
N/A |
| Biology of Bladder Cancer (R01 Clinical Trial Optional) |
PAR-25-129 |
01/05/2025 |
09/08/2025 |
R01 |
| Biology of Bladder Cancer (R21 Clinical Trial Optional) |
PAR-25-128 |
01/16/2025 |
09/08/2025 |
R21 |
| The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed) |
PAR-25-130 |
05/20/2025 |
06/21/2025 |
U01 |
| Notice of Special Interest (NOSI): Basic Mechanisms of Cannabis and Cannabinoid Action in Cancer |
NOT-CA-22-085 |
05/05/2022 |
05/08/2027 |
N/A |
| Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed) |
PAR-22-085 |
05/05/2022 |
05/08/2025 |
R01 |
| Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed) |
PAR-22-086 |
05/16/2022 |
05/08/2025 |
R21 |
| Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) |
PAR-25-171 |
01/05/2025 |
05/08/2025 |
R01 |
| Notice of Special Interest (NOSI): Developing Academic Research Enhancement Award (AREA) and Research Enhancement Award Program (REAP) for Institutions with an emphasis on Down syndrome research (R15 Clinical Trial Not Allowed) |
NOT-OD-22-136 |
05/31/2022 |
04/11/2025 |
N/A |
| Development of Animal Models and Related Biological Materials for Down Syndrome Research (R24 Clinical Trials Not-Allowed) |
PAR-22-247 |
11/01/2022 |
05/26/2025 |
R24 |
| Notice of Special Interest (NOSI): NIH Research Project Grants on Down Syndrome (R01) for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project |
NOT-OD-22-123 |
05/26/2022 |
05/01/2025 |
R01 |
| Notice of Special Interest (NOSI): Availability of Administrative Supplements for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project |
NOT-OD-22-137 |
06/07/2022 |
06/02/2025 |
N/A |
| Development of Animal Models and Related Biological Materials for Down Syndrome Research (R21 Clinical Trials Not Allowed) |
PAR-23-067 |
02/20/2023 |
01/08/2026 |
R21 |
